Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells

Title
Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells
Authors
Keywords
multiple myeloma, proteasome inhibitor, glutaminase, carfilzomib
Journal
Oncotarget
Volume 8, Issue 22, Pages -
Publisher
Impact Journals, LLC
Online
2017-03-17
DOI
10.18632/oncotarget.16262

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started